Stress-induced hyperthermia in mice: effects of flesinoxan on heart rate and body temperature

European Journal of Pharmacology

Volumn 400, Issue 1, 2000, Pages 59-66

  Bouwknecht, J Adriaan ^a   Hijzen, Theo H ^a   Van Der Gugten, Jan ^a   Maes, Robert A A ^a   Olivier, Berend ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b PSYCHOGENICS INC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(1A) receptor; Anxiety; Hyperthermia; Radiotelemetry; Stress; Tachycardia

Indexed keywords

FLESINOXAN; SEROTONIN 1A AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPERTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; STRESS; TACHYCARDIA; TELEMETRY; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BODY TEMPERATURE; FEVER; HEART RATE; MALE; MICE; PIPERAZINES; SEROTONIN AGONISTS; STRESS; TELEMETRY;

EID: 0034648051     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00387-3     Document Type: Article

References (61)

1. Borsini F., Lecci A., Volterra G., Meli A. A model to measure anticipatory anxiety in mice? Psychopharmacology. 98:1989;207-211.
2. Buisson D.S., Hibert M., Van den Buuse M. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. Fundam. Clin. Pharmacol. 7:1993;499-511.
3. 1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure. J. Pharmacol. Exp. Ther. 269:1994;215-220.
4. 1A receptor agonist, flesinoxan, in anaesthetized, normotensive rat. Br. J. Pharmacol. 112:1994;214-218.
5. De Koning P., De Vries M.H. A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers. Br. J. Clin. Pharmacol. 39:1995;7-14.
6. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-26.
7. Dedeoglu A., Fisher L.A. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor. Am. J. Physiol. 267:1994;R859-R864.
8. 1A receptors? Eur. J. Pharmacol. 262:1994;205-215.
9. 1A receptor agonist flesinoxan in the cat. J. Cardiovasc. Pharmacol. 14:1989;770-776.
10. 1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Eur. J. Pharmacol. 180:1990;339-349.
11. 1A receptor antagonist. Behav. Brain Res. 73:1995;337-353.
12. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
13. Gelfin Y., Lerer B., Lesch K.P., Gorfine M., Allolio B. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology. 120:1995;356-364.
14. Goa K.L., Ward A. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs. 32:1986;114-129.
15. 1 function. Neuropharmacology. 24:1985;1187-1194.
16. Goodwin G.M., De Souza R.J., Green A.R., Heal D.J. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology. 91:1987;506-511.
17. 1A receptor agonist, are not related to its neuroendocrine effects. Eur. J. Pharmacol. 280:1995;185-193.
18. Groenink L., Compaan J., Van der Gugten J., Zethof T., Van der Heyden J., Olivier B. Stress-induced hyperthermia in mice. Pharmacological and endocrinological aspects. Ann. N.Y. Acad. Sci. 771:1995;252-256.
19. Groenink L., Van der Gugten J., Zethof T.J.J., Van der Heyden J.A.M., Olivier B. Neuroendocrine effects of diazepam and flesinoxan in the stress-induced hyperthermia test in mice. Pharmacol. Biochem. Behav. 54:1996;249-254.
20. Grohs J.G., Fischer G., Raberger G. Cardiovascular effects of flesinoxan in anaesthetized and conscious dogs. Naunyn Schmiedeberg's Arch. Pharmacol. 341:1990;472-475.
21. Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J. Neural Transm. 61:1985;131-135.
22. Hof R.P., Fozard J.R. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits. Br. J. Pharmacol. 96:1989;864-871.
23. 1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur. J. Pharmacol. 143:1987;221-228.
24. Korte S.M., Bohus B. The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats. Eur. J. Pharmacol. 181:1990;307-310.
25. Lecci A., Borsini F., Mancinelli A., D'Aranno V., Stasi M.A., Volterra G., Meli A. Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice. J. Neural Transm.: Gen. Sect. 82:1990;219-230.
26. Lecci A., Borsini F., Volterra G., Meli A. Pharmacological validation of a novel animal model of anticipatory anxiety in mice. Psychopharmacology. 101:1990;255-261.
27. Lechin F., Van der Dijs B., Jara H., Orozco B., Baez S., Benaim M., Lechin M., Lechin A. Effects of buspirone on plasma neurotransmitters in healthy subjects. J. Neural Transm. 105:1998;561-573.
28. Leonard B.E. Tricyclic antidepressants: effective, cheap but are they safe? J. Psychopharmacol. 10:1996;35-38.
29. 1A receptor responsivity in anxiety disorders and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;723-733.
30. 1A receptor activation in humans. Eur. J. Clin. Pharmacol. 39:1990;17-19.
31. 1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br. J. Pharmacol. 107:1992;15-21.
32. 1A receptor agonists in mice. Eur. J. Pharmacol. 181:1990;295-297.
33. 1A receptor agonists. J. Pharmacol. Exp. Ther. 271:1994;776-781.
34. Molewijk H.E., Hartog K., Van der Poel A.M., Mos J., Olivier B. Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs. Psychopharmacology. 128:1996;31-38.
35. Murphy D.L., Lesch K.P., Aulakh C.S., Pigott T.A. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol. Rev. 43:1991;527-552.
36. Nemeroff C.B. Psychopharmacology of affective disorders in the 21st century. Biol. Psychiatry. 44:1998;517-525.
37. O'Hanlon J.F. Review of buspirone's effects on human performance and related variables. Eur. Neuropsychopharmacol. 1:1991;489-501.
38. Olivier B., Molewijk E., Van Oorschot R., Van der Poel G., Zethof T., Van der Heyden J., Mos J. New animal models of anxiety. Eur. Neuropsychopharmacol. 4:1994;93-102.
39. Olivier B., Molewijk E., Groenink L., Joordens R., Zethof T., Mos J. Potential animal models for the study of antipanic and antiphobic treatment. Westenberg H.G.M., den Boer J.A., Murphy D.L. Advances in the Neurobiology of Anxiety Disorders. 1997;83-105 Wiley, New Sussex.
40. 1A receptor mediated. Eur. J. Pharmacol. 342:1998;177-182.
41. Patel S., Hutson P.H. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse. Eur. J. Pharmacol. 317:1996;197-204.
42. 1A agonist: effects on physiological and psychological variables and blood serotonin levels. Neuropsychobiology. 28:1993;37-42.
43. Ratey J., Sovner R., Parks A., Rogentine K. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J. Clin. Psychiatry. 52:1991;159-162.
44. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology. 125:1996;89-91.
45. Roth B.L. Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatry. 6:1994;67-78.
46. 1A receptors play an important role in modulation of behavior of rats in a two-compartment black and white box. Behav. Pharmacol. 7:1996;788-797.
47. 1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology. 13:1995;93-104.
48. Shiah I.S., Yatham L.N., Lam R.W., Tam E.M., Zis A.P. Cortisol, hypothermic, and behavioral responses to ipsapirone in patients with bipolar depression and normal controls. Neuropsychobiology. 38:1998;6-12.
49. Southwick S.M., Paige S., Morgan C.A. III, Bremner J.D., Krystal J.H., Charney D.S. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin. Clin. Neuropsychiatry. 4:1999;242-248.
50. 1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology. 128:1996;293-303.
51. Stiedl O., Spiess J. Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav. Neurosci. 111:1997;703-711.
52. Unrug A., Bener J., Barry R.J., Van Luijtelaar E.L., Coenen A.M., Kaiser J. Influence of diazepam and buspirone on human heart rate and the evoked cardiac response under varying cognitive load. Int. J. Psychophysiol. 25:1997;177-184.
53. Van der Heyden J.A., Zethof T.J., Olivier B. Stress-induced hyperthermia in singly housed mice. Physiol. Behav. 62:1997;463-470.
54. Van Praag H.M. 5-HT-related, anxiety-and/or aggression-driven depression. Int. Clin. Psychopharmacol. 9(Suppl. 1):1994;5-6.
55. Vasey M.W., Thayer J.F. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology. 24:1987;479-486.
56. 1A receptors. Eur. J. Pharmacol. 149:1988;213-223.
57. 1A receptors and relationship to anxiolytic effect. Eur. J. Pharmacol. 323:1997;59-68.
58. 1A presynaptic function in the mouse. Psychopharmacology. 114:1994;360-364.
59. Zethof T.J., Van der Heyden J.A., Tolboom J.T., Olivier B. Stress-induced hyperthermia in mice: a methodological study. Physiol. Behav. 55:1994;109-115.
60. Zethof T.J.J., Van der Heyden J.A.M., Tolboom J.T.B.M., Olivier B. Stress-induced hyperthermia as a putative anxiety model. Eur. J. Pharmacol. 294:1995;125-135.
61. Zethof T.J.J., Van der Heyden J.A.M., Olivier B. Models of anxiety: stress-induced hyperthermia in group-housed mice. Curr. Protocols Pharmacol. 4:1998;5.16.1-5.16.11.